Litifilimab was superior to placebo for reducing skin disease activity in cutaneous lupus erythematosus, according to phase 2 ...

As the 2026 American Academy of Dermatology (AAD) annual meeting continues in Denver, MedPage Today is offering another ...

Research presented at the 2026 AAD Annual Meeting examined patterns of skin cancer prevalence in adults aged 50 years and ...

A dermatologist’s blunt ranking of popular skincare ingredients is gaining attention after he broke down what actually works—and what may be more hype than science. Experts have long pointed to a core ...

Rewarding and incentivizing physicians to provide high quality care at a lower cost — who can object to that? The idea of value-based care is as attractive to dermatologists as it is to other ...

Todd Schlesinger, MD, discusses how new immunotherapies and multidisciplinary care are reshaping treatment approaches for patients with advanced skin cancers. This content was developed independently ...